newsfilter
← Latest News
GlobeNewswire·

Opus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update

OPGx-BEST1 Cohort 1 Topline Data Expected in Second Week of September 2026 Enrollment Completed in LCA5 Registrational Trial with Dosing Planned for Q4 2026 RDH12, MERTK and RHO Programs Advancing with Upcoming